Trak
Livermore
About Trak
Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home. Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2018)
- Website: trakfertility.com
- Phone: 925-315-7246
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/trak-85443 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.